120 related articles for article (PubMed ID: 8380639)
1. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
Adham N; Kao HT; Schecter LE; Bard J; Olsen M; Urquhart D; Durkin M; Hartig PR; Weinshank RL; Branchek TA
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):408-12. PubMed ID: 8380639
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.
Lovenberg TW; Erlander MG; Baron BM; Racke M; Slone AL; Siegel BW; Craft CM; Burns JE; Danielson PE; Sutcliffe JG
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2184-8. PubMed ID: 8384716
[TBL] [Abstract][Full Text] [Related]
3. Development of 2-Aminotetralin-Type Serotonin 5-HT
McGlynn RP; Cui M; Brems B; Holbrook O; Booth RG
ACS Chem Neurosci; 2024 Jan; 15(2):357-370. PubMed ID: 38150333
[TBL] [Abstract][Full Text] [Related]
4. The discovery, structure, and function of 5-HTR1E serotonin receptor.
Sharma VK; Loh YP
Cell Commun Signal; 2023 Sep; 21(1):235. PubMed ID: 37723479
[TBL] [Abstract][Full Text] [Related]
5. Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.
Do TP; Deligianni C; Amirguliyev S; Snellman J; Lopez CL; Al-Karagholi MA; Guo S; Ashina M
Brain; 2023 Dec; 146(12):5224-5234. PubMed ID: 37540009
[TBL] [Abstract][Full Text] [Related]
6. Profile of Lasmiditan in the Acute Treatment of Migraine in Adults: Design, Development, and Place in Therapy.
Anderson CC; VanderPluym JH
Drug Des Devel Ther; 2023; 17():1979-1993. PubMed ID: 37426628
[TBL] [Abstract][Full Text] [Related]
7. The role of hippocampal 5-HT
Afshar S; Shahidi S; Baooshi H; Hoseini M; Esmaeili M; Hashemi-Firouzi N; Komaki A
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1451-1460. PubMed ID: 36749399
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms.
Körtési T; Spekker E; Vécsei L
Cells; 2022 Nov; 11(23):. PubMed ID: 36497053
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the ligand binding and G
Tan Y; Xu P; Huang S; Yang G; Zhou F; He X; Ma H; Xu HE; Jiang Y
Cell Discov; 2022 May; 8(1):50. PubMed ID: 35610220
[TBL] [Abstract][Full Text] [Related]
10. "Selective" serotonin 5-HT
Casey AB; Cui M; Booth RG; Canal CE
Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208
[TBL] [Abstract][Full Text] [Related]
11. Molecular Cloning and Functional Characterization of Three 5-HT Receptor Genes (
Sun C; Qiu Y; Ren Q; Zhang X; Cao B; Zou Y; Li J; Zhang J; Wang Y
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207786
[TBL] [Abstract][Full Text] [Related]
12. Intercellular Communication in the Islet of Langerhans in Health and Disease.
Ng XW; Chung YH; Piston DW
Compr Physiol; 2021 Jun; 11(3):2191-2225. PubMed ID: 34190340
[TBL] [Abstract][Full Text] [Related]
13. Lasmiditan mechanism of action - review of a selective 5-HT
Clemow DB; Johnson KW; Hochstetler HM; Ossipov MH; Hake AM; Blumenfeld AM
J Headache Pain; 2020 Jun; 21(1):71. PubMed ID: 32522164
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic modulation across sensory modalities.
Sizemore TR; Hurley LM; Dacks AM
J Neurophysiol; 2020 Jun; 123(6):2406-2425. PubMed ID: 32401124
[TBL] [Abstract][Full Text] [Related]
15. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system.
Labastida-Ramírez A; Rubio-Beltrán E; Haanes KA; Chan KY; Garrelds IM; Johnson KW; Danser AHJ; Villalón CM; MaassenVanDenBrink A
Pain; 2020 May; 161(5):1092-1099. PubMed ID: 31977930
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
17. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α
González-Hernández A; Lozano-Cuenca J; Marichal-Cancino BA; MaassenVanDenBrink A; Villalón CM
J Headache Pain; 2018 May; 19(1):40. PubMed ID: 29802544
[TBL] [Abstract][Full Text] [Related]
18. Targeted 5-HT
Vila-Pueyo M
Neurotherapeutics; 2018 Apr; 15(2):291-303. PubMed ID: 29488143
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.
Falkenberg K; Dunga BÓÁ; Guo S; Ashina M; Olesen J
J Headache Pain; 2018 Feb; 19(1):11. PubMed ID: 29396788
[TBL] [Abstract][Full Text] [Related]
20. Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells.
Almaça J; Molina J; Menegaz D; Pronin AN; Tamayo A; Slepak V; Berggren PO; Caicedo A
Cell Rep; 2016 Dec; 17(12):3281-3291. PubMed ID: 28009296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
